Xbrane Biopharma AB (STU:7XB) Change In Inventory : €-11.52 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Xbrane Biopharma AB Change In Inventory?

Xbrane Biopharma AB's change in inventory for the quarter that ended in Mar. 2024 was €-7.11 Mil. It means Xbrane Biopharma AB's inventory increased by €7.11 Mil from Dec. 2023 to Mar. 2024 .

Xbrane Biopharma AB's change in inventory for the fiscal year that ended in Dec. 2023 was €-5.06 Mil. It means Xbrane Biopharma AB's inventory increased by €5.06 Mil from Dec. 2022 to Dec. 2023 .

Xbrane Biopharma AB's Total Inventories for the quarter that ended in Mar. 2024 was €16.55 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Xbrane Biopharma AB's Days Inventory for the quarter that ended in Mar. 2024 was 2,815.38.

Inventory Turnover measures how fast the company turns over its inventory within a year. Xbrane Biopharma AB's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Xbrane Biopharma AB's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 10.47.

Xbrane Biopharma AB Change In Inventory Historical Data

The historical data trend for Xbrane Biopharma AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB Change In Inventory Chart

Xbrane Biopharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-4.57

-5.06

Xbrane Biopharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-0.31	-3.56	-3.25	2.40	-7.11

Xbrane Biopharma AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.52 Mil.

Xbrane Biopharma AB (STU:7XB) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Xbrane Biopharma AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	13.051	/	0.423	*	365 / 4
	=	2,815.38

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Xbrane Biopharma AB's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.423	/	13.051
	=	0.03

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Xbrane Biopharma AB's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	13.051	/	1.246
	=	10.47

Xbrane Biopharma AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Xbrane Biopharma AB (STU:7XB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (STU:7XB) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

XBRANE:Sweden 7XB:Germany

Address

Retzius vag 8, Solna, SWE, 171 65

Website

https://www.xbrane.com

Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company has a patented protein production platform with up to 12 times greater productivity than standard systems for the production of proteins in E.coli host cells. Xbrane's leading product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration. The company's geographical segments include the Middle East, Asia, Europe, and the United States.

Xbrane Biopharma AB (STU:7XB) Headlines

No Headlines